Ecolab Inc. (ECL - Free Report) recently introduced its Pest Elimination Rodent Ceiling Service, which will offer additional monitoring and protection with hard-to-access ceiling areas. This new service is likely to provide a boost to the company’s Other Segment that comprises of two units — Pest Elimination and Equipment Care and are primarily fee-for-service businesses.
Notably, Ecolab’s Rodent Ceiling Service is an effective new solution that helps in proactive elimination of rodent activity in ceiling areas where it’s hard to reach, thereby reducing risks associated with rodents.
Benefits of Ecolab’s Rodent Ceiling Service
Rodents have managed to become an increasing threat to food safety and brand reputation across the supply chain. Per the U.S Centers for Disease Control and Prevention (CDC), rodents are able to contaminate food and food surfaces and can transmit over 35 diseases to humans.
The Rodent Ceiling Service — an extension of Ecolab Pest Elimination’s outside-in- approach — is a new way of ceiling monitoring that will help to detect and resolve rodent activity quickly and protect public health. Moreover, this service will benefit foodservice operators by lowering the risk of costly shut-downs and protect brands from the threat posed by rodent activity.
Ecolab — the global leader in water, hygiene and infection prevention solutions and services — remains focused in developing innovating ways to protect customers against the threats posed to food safety and their business reputation by pests.
On Jun 17, Ecolab unveiled its Science Certified Program that utilizes a comprehensive, science-based approach and combines advanced chemistry with new public health training and audit verification to offer a high standard of cleanliness for public health and food safety necessary on account of the COVID-19 pandemic.
According to a report by Research and Markets, the global food safety and hygiene compliance market is expected to see a CAGR of 6% to $15.3 billion by 2027. Hence, Ecolab’s launch of this service is a well-timed one.
This Zacks Rank #4 (Sell) stock has gained 4.5% in a year’s time compared with the industry’s growth of 31.5%.
Stocks to Consider
Some better-ranked stocks from the broader medical space include Quest Diagnostics Incorporated (DGX - Free Report) , Laboratory Corporation of America Holdings (LH - Free Report) and West Pharmaceutical Services, Inc. (WST - Free Report) . While West Pharmaceutical sports a Zacks Rank #1 (Strong Buy), Quest Diagnostics and Laboratory Corporation carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
West Pharmaceutical has a projected long-term earnings growth rate of 9.2%.
Quest Diagnostics has an estimated long-term earnings growth rate of 7.6%.
Laboratory Corporation has an estimated long-term earnings growth rate of 6.1%.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>